|
Dr. Angelina Duggan is a Managing Scientist in Exponent’s Health Sciences practice. She is an organic chemist and toxicologist with more than 25 years experience in pharmaceutical and agrochemical product development and global regulatory affairs that includes the organization and project management of multi-disciplinary teams. Dr. Duggan integrates toxicology biomonitoring exposure physicochemical and epidemiology data for FIFRA and TSCA registrations and risk assessments. She also provides technical support for agrochemical and pharmaceutical discovery and process patents data compensation and due diligence evaluations of toxicology and product chemistry databases.
Dr. Duggan is widely recognized as an endocrine disruption and children’s health science and policy expert. She was appointed by EPA to serve on the Endocrine Disruption Screening and Testing Advisory Committee (EDSTAC) and the Children’s Health Protection Advisory Committee and wrote significant portions of the EDSTAC Final Report. She has advised task forces and led multi-disciplinary working groups and issues management teams in evaluating children’s health cancer risk assessment farm family exposures human testing and endocrine di sruption. Before joining Exponent Dr. Duggan provided scientific guidance for Washington DC trade associations pesticide and chemical manufacturers and formulators regarding EPA and State regulations and human health science and policy.
Dr. Duggan effectively communicates risk and policy to scientists and non-scientists and is accomplished in media relations including interviews with the trade and popular press. She has presented and provided written public comments to EPA workshops and Science Advisory Panels and Boards. Dr. Duggan has also authored and organized the submission of numerous technical and regulatory science policy papers to EPA’s Public Docket. Her project management experience includes multi-disciplinary litigation teams discovery R&D and process chemistry regulatory affairs global safety and product stewardship audits and presenting agrochemical product profiles to EPA Latin American European and Asian regulators. She has also developed and implemented agrochemical biotechnology and discovery screening strategic plans and has extensive experience in global regulatory affairs and business management; including data compensation and distributor supply agreements. | 